BUZZ-Moderna climbs on smaller-than-expected Q3 loss
Reuters
Nov 06
BUZZ-<a href="https://laohu8.com/S/MRNA">Moderna</a> climbs on smaller-than-expected Q3 loss
** Shares of vaccine maker Moderna MRNA.O rise 6.4% to $25.07 premarket
** Co reports Q3 loss of 51 cents/shr vs analysts' average loss estimate of $2.11/shr - LSEG data
** Co's quarterly revenue of $1 billion beats analysts' average expectation of $886.5 million
** MRNA lowers the top end of its 2025 revenue forecast by $200 million on weaker-than-expected sales of its COVID-19 vaccine in the U.S
** Up to last close, stock down ~43% YTD
(Reporting by Sahil Pandey and Christy Santhosh in Bengaluru)
((Sahil.Pandey@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.